DarioHealth Corp. (DRIO)
| Market Cap | 80.14M |
| Revenue (ttm) | 24.73M |
| Net Income (ttm) | -33.99M |
| Shares Out | 6.77M |
| EPS (ttm) | -11.36 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,651 |
| Open | 12.40 |
| Previous Close | 12.05 |
| Day's Range | 11.77 - 12.40 |
| 52-Week Range | 5.94 - 31.00 |
| Beta | 1.07 |
| Analysts | Strong Buy |
| Price Target | 50.00 (+322.3%) |
| Earnings Date | Nov 13, 2025 |
About DRIO
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral heal... [Read more]
Financial Performance
In 2024, DarioHealth's revenue was $27.04 million, an increase of 32.86% compared to the previous year's $20.35 million. Losses were -$30.09 million, -45.15% less than in 2023.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for DRIO stock is "Strong Buy." The 12-month stock price target is $50.0, which is an increase of 322.30% from the latest price.
News
Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio
Peer-reviewed JMIR Cardio study demonstrates real-world clinical impact of data-driven digital nudges on hypertension outcomes Data-driven engagement translates to lower health risks and downstream co...
DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date
34 new employer clients added in the past two weeks expected to contribute to H1 2026 revenue Data-driven outcomes drive employer adoption, highlighting Dario's market leadership as partner of choice,...
DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year
Sanofi and Symphony Health teams conducted the study demonstrating how Dario's digital, diabetes intervention platform reduces real-world healthcare burden and cost compared to usual care Representing...
DarioHealth Corp. (DRIO) Q3 2025 Earnings Call Transcript
DarioHealth Corp. ( DRIO) Q3 2025 Earnings Call November 13, 2025 8:30 AM EST Company Participants Zoe Harrison Erez Raphael - CEO & Director Steven Nelson - President & Chief Commercial Officer Chen...
DarioHealth Reports Third Quarter 2025 Financial and Operating Results
Third quarter 2025 revenue was $5.0 million, compared to $7.4 million in the third quarter of 2024, and $5.4 million in the second quarter of 2025 Targeting $12.4 million in new business, reflecting b...
DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform
Analysis based on claims data highlights significant cost savings, especially among high-risk members NEW YORK , Nov. 12, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHe...
DarioHealth to Report Third Quarter 2025 Results on Thursday, November 13, 2025
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK , Nov. 6, 2025 /PRNewswire/ --DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital...
Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives Deepening its Leadership in Value-Based Care
New clients span multiple industries and underscore broad increasing demand for Dario's multi-condition digital health platform Innovative new pricing model is highly attractive to prospective clients...
DarioHealth and OneStep Announce Strategic Collaboration to Integrate Smartphone-Only, Clinical-Grade Fall Risk Assessment Technology into Dario's Digital Health Multi-Condition Platform
Collaboration designed to drive measurable return on investment ("ROI") for health plans by reducing falls and improving outcomes for high-risk populations, including those with obesity and Medicare A...
DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest
Board forms Special Committee and engages Perella Weinberg Partners as financial advisor Company completed an oversubscribed $17.5 million private placement to capitalize on significant commercial mom...
DarioHealth Announces $17.5 Million Private Placement of Common Stock Priced At-The-Market Under Nasdaq Rules
NEW YORK , Sept. 22, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a private placement for the purchas...
DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market
NEW YORK , Sept. 3, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today issued a shareholder update highlighting strat...
Dario Secures Five New Employer Contracts Across Cardiometabolic Suite Including its Largest Employer to Date, Contributing to Annual Recurring Revenues Beginning Q3 2025
New customer launches representing 107,000 lives covered reinforce Dario's B2B2C momentum and recurring revenue growth Dario's multi-condition digital health solutions deliver real-time results for pr...
DarioHealth Announces 20-to-1 Reverse Stock Split
NEW YORK , Aug. 25, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced that a reverse stock split of the Co...
DarioHealth Corp. (DRIO) Q2 2025 Earnings Call Transcript
DarioHealth Corp. (NASDAQ:DRIO) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Chen Franco-Yehuda - CFO, Treasurer & Secretary Erez Raphael - CEO & Director Steven C...
DarioHealth Reports Second Quarter 2025 Financial and Operating Results
Second quarter 2025 revenue was $5.4 million, compared to $6.3 million in the second quarter of 2024, and $6.8 million in the first quarter of 2025 - The Company believes that strong client momentum a...
DarioHealth to Report Second Quarter 2025 Results on Tuesday, August 12, 2025
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK , Aug. 5, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digita...
Dario and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide
Dario and GreenKey Join Forces to Target $150 Billion Sleep Apnea Market, Addressing 29 Million Americans with Unmet Needs Through Integrated Chronic Care Solution NEW YORK and SAN FRANCISCO , June 26...
Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings
Dario's new research shows sustained outcomes post-GLP-1 for platform users and 89% accuracy in innovative AI blood glucose prediction; the Company is actively working to leverage these findings in co...
DarioHealth Corp. (DRIO) Q1 2025 Earnings Call Transcript
DarioHealth Corp. (NASDAQ:DRIO) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Lara Dod...
DarioHealth Reports First Quarter 2025 Financial and Operating Results
First quarter revenue of $6.75 million, a 17% increase year-over-year, driven by employer and health plan (B2B2C) growth, and a decrease of 11% sequentially. Gross margin increased to 57.5% compared t...
Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
New data, published in JMIR, demonstrates the value of personalized messaging encouraging flu vaccinations in Dario members with diabetes NEW YORK , May 8, 2025 /PRNewswire/ -- DarioHealth Corp. (NASD...
DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK , May 7, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital...
DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives
$32.5 million funded at close; up to $17.5 million of additional capital available at the Company's option, subject to the achievement of certain revenue thresholds. Capital from the transaction is ex...
DarioHealth Announces CFO Transition
NEW YORK , April 21, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leading global digital health company, today announced that Zvi Ben-David , Chief Financial Off...